Search Contract Opportunities

Bulk Pharmaceuticals - Group A (Materiel)

ID: 75A50325R00002 • Type: Synopsis Solicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: March 28, 2025, 5:49 p.m. EDT

THIS AMENDMENT IS ISSUED TO REVISE THE SOLICITED QUANTITIES AND REVISE STATEMENT OF WORK SECTION D.3.3 - RETURNS & RECALLS. QUANTITIES ARE REVISED IN RFP ATTACHMENT 1 AND RFP ATTACHMENT 2.

THE CLOSING DATE OF THE SOLICITATION IS EXTENDED TO APRIL 3, 2025, AT 11:00 A.M. (EST).

*********************************************************************************

THIS AMENDMENT IS ISSUED TO PUBLISH ANSWERS TO VENDOR QUESTIONS. PLEASE SEE ATTACHED "ANSWERS TO VENDOR QUESTIONS."

***************************************************

This is a combined synopsis/solicitation for commercial supplies in accordance with FAR Part 12. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This synopsis/solicitation is issued on the basis of full and open competition and is not set aside for small businesses. The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing). The size standard is 1,300 (number of employees).

The Center for the Strategic National Stockpile (SNS) has a need to procure a variety of FDA-approved pharmaceuticals to maintain minimum stockpiling capabilities for responding to public health events. The Contractor, as an independent organization and not as an agent of the Government, shall furnish all labor, materials, supplies, facilities, equipment, transportation and travel necessary to deliver the acceptable pharmaceuticals. The Contractor shall provide brand name or equal product for the pharmaceuticals listed in Section D - Description/Specifications/Work Statement contained in the Request for Proposals. The pharmaceuticals include the following:

Albuterol Nebulizer Solution, 0.083% - 2.5mg/3ml vial

Amoxicillin/Clavulanate Acid 500mg/125mg tablets

Bactrim DS, sulfamethoxazole 800mg/trimethoprim 160mg, 100 tablets

Doxycycline 25mg/5ml oral suspension, powder, 60ml bottle

Ondansetron HCL 8mg, 30 tablets, bottle

Penicillin G Potassium 20MU vial

Sodium Chloride (NaCl), 0.9% for injection, 100ml solution flexi-bag

Voriconazole 200mg, 30 Tablet Bottle

Large business offerors shall submit small business subcontracting plans by the closing date and time of this announcement to: https://osdbu.hhs.gov/subcontracting/fa0d5019-799c-45ba-b5e9-3275cc971e2f

Posted: March 24, 2025, 3:59 p.m. EDT
Posted: March 10, 2025, 10:28 a.m. EDT
Background
The Center for the Strategic National Stockpile (SNS) is seeking to procure a variety of FDA-approved pharmaceuticals to ensure readiness for public health emergencies. This solicitation is part of the agency's mission to maintain adequate stockpiling capabilities in response to health events. The contract is issued under full and open competition, with no set-aside for small businesses.

Work Details
The contractor will provide the following pharmaceuticals:
- Albuterol Nebulizer Solution, 0.083% - 2.5mg/3ml vial
- Amoxicillin/Clavulanate Acid 500mg/125mg tablets
- Bactrim DS, sulfamethoxazole 800mg/trimethoprim 160mg, 100 tablets
- Doxycycline 25mg/5ml oral suspension, powder, 60ml bottle
- Ondansetron HCL 8mg, 30 tablets, bottle
- Penicillin G Potassium 20MU vial
- Sodium Chloride (NaCl), 0.9% for injection, 100ml solution flexi-bag
- Voriconazole 200mg, 30 Tablet Bottle.

The contractor must furnish all necessary labor, materials, supplies, facilities, equipment, transportation and travel to deliver these pharmaceuticals.

Overview

Response Deadline
April 3, 2025, 11:00 a.m. EDT (original: March 31, 2025, 11:00 a.m. EDT) Past Due
Posted
March 10, 2025, 10:28 a.m. EDT (updated: March 28, 2025, 5:49 p.m. EDT)
Set Aside
None
Place of Performance
GA United States
Source

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 3/10/25 HHS Office of the Assistant Secretary for Preparedness and Response issued Synopsis Solicitation 75A50325R00002 for Bulk Pharmaceuticals - Group A (Materiel) due 4/3/25. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Terri Reed   Profile
Phone
None

Secondary Contact

Name
Kimberly Golden   Profile
Phone
None

Documents

Posted documents for Synopsis Solicitation 75A50325R00002

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Contract Awards

Prime contracts awarded through Synopsis Solicitation 75A50325R00002

Incumbent or Similar Awards

Contracts Similar to Synopsis Solicitation 75A50325R00002

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation 75A50325R00002

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation 75A50325R00002

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > ASPR/ORM-SNS
FPDS Organization Code
7505-75A503
Source Organization Code
500175942
Last Updated
April 18, 2025
Last Updated By
terri.reed@hhs.gov
Archive Date
April 18, 2025